Psychological Stress and Depression: Risk Factors for IBD?

Digestive Diseases

Volumn 34, Issue 1-2, 2016, Pages 58-63

  Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Brain gut axis; Inflammatory bowel disease; Mood and anxiety disorders; Stress

Indexed keywords

ANXIETY DISORDER; COMORBIDITY; CONFERENCE PAPER; COPING BEHAVIOR; CROHN DISEASE; DEPRESSION; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MAJOR DEPRESSION; MENTAL STRESS; MOOD DISORDER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; ULCERATIVE COLITIS; ANIMAL; INFLAMMATORY BOWEL DISEASES; PSYCHOLOGY;

ANIMALS; COMORBIDITY; DEPRESSION; HUMANS; INFLAMMATORY BOWEL DISEASES; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84962459982     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000442929     Document Type: Conference Paper

References (69)

1. Graff LA, Walker JR, Clara I, et al: Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls. Am J Gastroenterol 2009; 104: 2959-2969.
2. Lix LM, Graff LA, Walker JR, et al: Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 2008; 14: 1575-1584.
3. Kessler RC, Berglund P, Demler O, et al: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095-3105.
4. Patten SB, Wang JL, Williams JV, et al: Descriptive epidemiology of major depression in Canada. Can J Psychiatry 2006; 51: 84-90.
5. Kessler RC, Berglund P, Demler O, et al: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
6. Graff LA, Walker JR, Bernstein CN: Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management. Inflamm Bowel Dis 2009; 15: 1105-1118.
7. Walker JR, Ediger JP, Graff LA, et al: The Manitoba IBD cohort study: A populationbased study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol 2008; 103: 1989-1997.
8. Guthrie E, Jackson J, Shaffer J, et al: Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol 2002; 97: 1994-1999.
9. Moradkhani A, Beckman LJ, Tabibian JH: Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. J Crohns Colitis 2013; 7: 467-473.
10. Zhang CK, Hewett J, Hemming J, et al: The influence of depression on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 1732-1739.
11. Insel TR, Charney DS: Research on major depression: strategies and priorities. JAMA 2003; 289: 3167-3168.
12. Irwin MR, Miller AH: Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007; 21: 374-383.
13. Yeragani VK, Pohl R, Jampala VC, et al: Increased QT variability in patients with panic disorder and depression. Psychiatry Res 2000; 93: 225-235.
14. Nair GV, Gurbel PA, O'Connor CM, et al: Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors. Am J Cardiol 1999; 84: 321-323.
15. Vieira MM, Ferreira TB, Pacheco PA, et al: Enhanced Th17 phenotype in individuals with generalized anxiety disorder. J Neuroimmunol 2010; 229: 212-218.
16. O'Brien SM, Scott LV, Dinan TG: Antidepressant therapy and C-reactive protein levels. Br J Psychiatry 2006; 188: 449-452.
17. Muller N: Immunology of major depression. Neuroimmunomodulation 2014; 21: 123-130.
18. Miller GE, Stetler CA, Carney RM, et al: Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90: 1279-1283.
19. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, et al: The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol Psychiatry 2006; 60: 825-830.
20. Mackner LM, Clough-Paabo E, Pajer K, et al: Psychoneuroimmunologic factors in inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 849-857.
21. Kaestner F, Hettich M, Peters M, et al: Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 2005; 87: 305-311.
22. Seidel A, Arolt V, Hunstiger M, et al: Cytokine production and serum proteins in depression. Scand J Immunol 1995; 41: 534-538.
23. Thomas AJ, Davis S, Morris C, et al: Increase in interleukin-1beta in late-life depression. Am J Psychiatry 2005; 162: 175-177.
24. Zorrilla EP, Luborsky L, McKay JR, et al: The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain Behav Immun 2001; 15: 199-226.
25. Anisman H, Merali Z: Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 2003; 35: 2-11.
26. Kim YK, Suh IB, Kim H, et al: The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry 2002; 7: 1107-1114.
27. Fries GR, Pfaffenseller B, Stertz L, et al: Staging and neuroprogression in bipolar disorder. Curr Psychiatry Rep 2012; 14: 667-675.
28. Gabbay V, Klein RG, Alonso CM, et al: Immune system dysregulation in adolescent major depressive disorder. J Affect Disord 2009; 115: 177-182.
29. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, et al: Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder. Int J Neuropsychopharmacol 2009; 12: 447-458.
30. Maes M, Berk M, Goehler L, et al: Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 2012; 10: 66.
31. Sudo N, et al: Postnatal microbial colonization programs the hypothalamic-pituitaryadrenal system for stress response in mice. J Physiol 2004; 558(pt 1):263-275.
32. Diaz Heijtz R, Wang S, Anuar F, et al: Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011; 108: 3047-3052.
33. Neufeld KM, Kang N, Bienenstock J, Foster JA: Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23: 255-264.
34. Bercik P, Denou E, Collins J, et al: The intestinal microbiota affect central levels of brainderived neurotropic factor and behavior in mice. Gastroenterology 2011; 141: 599-609.
35. Savignac HM, Kiely B, Dinan TG, Cryan JF: Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil 2014; 26: 1615-1627.
36. Bravo JA, et al: Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011; 108: 16050-16055.
37. Desbonnet L, Garrett L, Clarke G, et al: Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010; 170: 1179-1188.
38. Bercik P, Verdu EF, Foster JA, et al: Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010; 139: 2102-2112.
39. Messaoudi M, Violle N, Bisson JF, et al: Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2011; 2: 256-261.
40. Benton D, Williams C, Brown A: Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 2007; 61: 355-361.
41. Foster JA. McVey Neufeld KA: Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 2013; 36: 305-312.
42. Barrett E, Ross RP, O'Toole PW, et al: γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012; 113: 411-417.
43. Higuchi T, Hayashi H, Abe K: Exchange of glutamate and gamma-aminobutyrate in a Lactobacillus strain. J Bacteriol 1997; 179: 3362-3364.
44. Diaz Heijtz R, Wang S, Anuar F, et al: Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011; 108: 3047-3052.
45. Komatsuzaki N, Nakamura T, Kimura T, Shima J: Characterization of glutamate decarboxylase from a high gamma-aminobutyric acid (GABA)-producer, Lactobacillus paracasei. Biosci Biotechnol Biochem 2008; 72: 278-285.
46. Tsavkelova EA, Botvinko IV, Kudrin VS, Oleskin AV: Detection of neurotransmitter amines in microorganisms with the use of high-performance liquid chromatography. Dokl Biochem 2000; 372: 115-117.
47. Girvin GT, Stevenson JW: Cell free choline acetylase from Lactobacillus plantarum. Can J Biochem Physiol 1954; 32: 131-146.
48. Rowatt E: The relation of pantothenic acid to acetylcholine formation by a strain of Lactobacillus plantarum. J Gen Microbiol 1948; 2: 25-30.
49. Wikoff WR, Anfora AT, Liu J, et al: Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 2009; 106: 3698-3703.
50. Sudo N, Chida Y, Aiba Y, et al: Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004; 558(pt 1):263-275.
51. Bailey MT, Dowd SE, Galley JD, et al: Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 2011; 25: 397-407.
52. Galley JD, Nelson MC, Yu Z, et al: Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota. BMC Microbiol 2014; 14: 189.
53. Holdeman LV, Good IJ, Moore WE: Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol 1976; 31: 359-375.
54. Hankin BL: Future directions in vulnerability to depression among youth: integrating risk factors and processes across multiple levels of analysis. J Clin Child Adolesc Psychol 2012; 41: 695-718.
55. Maddock C, Pariante CM: How does stress affect you? An overview of stress, immunity, depression and disease. Epidemiol Psichiatr Soc 2001; 10: 153-162.
56. Patten SB: Major depression epidemiology from a diathesis-stress conceptualization. BMC Psychiatry 2013; 13: 19.
57. Mittermaier C, Dejaco C, Waldhoer T, et al: Impact of depressive mood on relapse in patients with inflammatory bowel disease: A prospective 18-month follow-up study. Psychosom Med 2004; 66: 79-84.
58. Persoons P, Vermeire S, Demyttenaere K, et al: The impact of major depressive disorder on the short-and long-term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther 2005; 22: 101-110.
59. Faust AH, Halpern LF, Danoff-Burg S, Cross RK: Psychosocial factors contributing to inflammatory bowel disease activity and healthrelated quality of life. Gastroenterol Hepatol (N Y) 2012; 8: 173-181.
60. Longobardi T, Bernstein CN: Health care resource utilization in inflammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4: 731-743.
61. Mikocka-Walus AA, Turnbull D, Holtmann G, Andrews JM: An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementation. Inflamm Bowel Dis 2012; 18: 1573-1581.
62. Acosta MBD, Iglesias M, Ferreiro R, et al: Depression is associated with a worse clinical course in inflammatory bowel disease. Gastroenterology 2013:abstr 1288.
63. Ananthakrishnan AN, Gainer VS, Perez RG, et al: Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease. Aliment Pharmacol Ther 2013; 37: 445-454.
64. Bennebroek Evertsz' F, Thijssens NA, Stokkers PC, et al: Do inflammatory bowel disease patients with anxiety and depressive symptoms receive the care they need? J Crohns Colitis 2012; 6: 68-76.
65. Singh S, Blanchard A, Walker JR, et al: Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2011; 9: 769-775.
66. Bernstein CN, Singh S, Graff LA, et al: A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol 2010; 105: 1994-2002.
67. Langhorst J, Hofstetter A, Wolfe F et al: Shortterm stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: A prospective 12-month follow-up study. Inflamm Bowel Dis 2013; 19: 2380-2386.
68. Targownik LE, Sexton KA, Bernstein MT, et al: The relationship among perceived stress, symptoms, and inflammation in persons with inflammatory bowel disease. Am J Gastroenterol 2015; 110: 1001-1012.
69. Bernstein MT, Sexton KA, Targownik LE, et al: Sources of stress in IBD and relation to disease activity. Gastroenterology 2013; 144: S632-S633.